UA102703C2 - Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
- Google Patents
Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
Государственное Высшее Учебное Заведение «Ужгородский Национальный Университет»
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение «Ужгородский Национальный Университет»filedCriticalГосударственное Высшее Учебное Заведение «Ужгородский Национальный Университет»
Priority to UAA201104973ApriorityCriticalpatent/UA102703C2/en
Publication of UA102703C2publicationCriticalpatent/UA102703C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to medicine, in particular to cardiology, and concerns the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricleandefference of treatment is estimated.
UAA201104973A2011-04-202011-04-20Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
UA102703C2
(en)
Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
Method for objective estimation of benidipine effect in patients with coronary heart disease accompanied by stenocardia and arterial hypertension with left ventricular hypertrophy
Method for estimation of efficiency of treatment with lerkanipidin of patients with ischemic heart disease with stenocardia and arterial hypertensia with disorder of left ventricle diastolic function by “hypertrophic” type
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Method for the assessment of efficiency of treatment with manidipine of patients suffered from coronary heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy with diastolic dysfunction
method for estimation of efficiency of treatment with talinilol of patients WITH ischemic heart DISEASE with stenocardia and arterial hypertensy with disorder of diastolIC function of the left ventricle by"hypertrophic" type
Method for assessing efficacy of s-metoprolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for estimation of efficiency of treatment with NITRENDIPINE of patients with ischemic heart disease with stenocardia and arterial hypertensia with disorder of left ventricle diastolic function by “hypertrophic” type
method for estimation of efficiency of treatment of patients with ischemic heart disease with stenocardia and arterial hypertensia with left ventricle diastolic function disorder by "hypertrophic" type with propranolol
method for estimation of efficiency of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type with metoprolol
method for estimation of efficiency of treatment with NADOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
method for estimation of efficiency of treatment with ALPRENOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
Method for assessing efficacy of rozuvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of irbesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
method for estimation of efficiency of treatment with LABETOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
method for estimation of efficiency of treatment with TIMOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
method for estimation of efficiency of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type with bisoprolol
Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle